Germany
Japan
United Kingdom
China
Anti-IGF1R / CD221 Reference Antibody (cixutumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Primary Antibodies
View as table DownloadAnti-IGF1R / CD221 Reference Antibody (teprotumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-IGF1R / CD221 Reference Antibody (lonigutamAb)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-IGF1R / CD221 Reference Antibody (Lonigutamab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-IGF1R / CD221 Reference Antibody (robatumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-IGF1R / CD221 Reference Antibody (ganitumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-IGF1R / CD221 Reference Antibody (figitumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-IGF1R / CD221 Reference Antibody (dalotuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- IGF1R / CD221
Isotypes
- IgG1
Conjugates
- Unconjugated
Assay Types
- Indirect